Creative Biolabs: Time to leap beyond old-school antibody discovery and embrace high throughput AI!

Feb. 10, 2025 - PRLog -- With the increasing use of personalized medicine and complex therapeutic targets, the requirement for high-quality antibodies has never been higher. High throughput antibody production is the only way to meet this challenge—by allowing researchers to generate large numbers of antibodies in short periods for screening and subsequent applications in therapies.

"It is not just about producing more antibodies but producing the right antibodies quickly and efficiently." A scientist at Creative Biolabs says.

Being one of the leading companies in the field of antibody development, Creative Biolabs takes this a step further with a set of services to optimize the processes of discovery and production using AI-driven technologies, which tremendously contribute to a variety of different discovery platforms, whether it be AI-driven lead discovery, single B cell isolation, or phage display.

High Throughput Antibody Production for AI-Driven Lead Discovery

In the AI era, AI-driven lead discovery has become a new driving force for finding and optimizing therapeutic antibodies. Creative Biolabs has integrated an AI algorithm capable of generating novel protein structures—millions of protein sequences were adopted to train AI in natural protein evolution strategies, allowing for the efficient engineering of human antibody molecules through evolutionarily viable mutations.

High Throughput Antibody Production for Single B Cell Antibody Discovery

Aware of the fact that single B cell antibody discovery represents the gold standard in the isolation of rare and highly specific antibodies, Creative Biolabs perfectly integrates the most advanced FACS technology with a tailored immunization strategy to offer researchers the chance to screen millions of B cells for identifying the best candidates for their needs.

The process involves isolating individual B cells, amplifying their genetic material, and producing monoclonal antibodies for downstream applications. As the scientist puts it, "This approach ensures we're getting the highest quality antibodies, straight from the source—without any shortcuts."

High Throughput Antibody Production for Phage Display-Mediated Antibody Discovery

Phage display is an established method for discovering antibodies of high specificity to their target antigens. High-throughput production for phage display-mediated antibody discovery at Creative Biolabs takes it up a notch, with high-throughput screening of large phage libraries for desirable binding properties, further high-yield production, and downstream analysis and application.

"The antibody library, when combined with solid-phase technology and high-throughput screening, can readily and rapidly acquire the desired antibodies, and we can not only offer a capacity of up to 10^8 antibody libraries but also provide antibody library construction services based on customer requirements." Says the scientist.

Visit their website to learn more: www.creativebiolabs.net